EichorEICHOR
Condition: Gi Disorders Synced from ClinicalTrials.gov · August 08, 2026

Recruiting studies: Gi Disorders

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Surgery Plus Chemo Versus Chemoradiotherapy Followed by Surgery Plus Chemo for Locally Recurrent Rectal Cancer
Phase 3 · 45 location(s) · National Cancer Center Hospital East · NCT04288999A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Phase 1 · 8 location(s) · Erasca, Inc. · NCT06983743Mechanism of Chronic Pain in Patients With IBD
Phase N/A · 1 location(s) · Queen Mary University of London · NCT04995224A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
Phase N/A · 59 location(s) · Eisai Korea Inc. · NCT06246123BioHealx® Anal Fistula Device Post Market Surveillance Study
Phase N/A · 6 location(s) · Signum Surgical USA Inc. · NCT07021742Futibatinib in Combination With (Chemo)Immunotherapy in Colorectal Cancer and Other Solid Tumor Entities
Phase 2 · 10 location(s) · Institut für Klinische Krebsforschung IKF GmbH at Krankenhau · NCT06722183A Prospective Natural History Study of Lymphatic Anomalies
Phase N/A · 2 location(s) · Eunice Kennedy Shriver National Institute of Child Health an · NCT05731141A Study to Monitor the Fruzaqla Treatment of Adults With Metastatic Colorectal Cancer (mCRC) in South Korea
Phase N/A · 1 location(s) · Takeda · NCT07035886Study to Evaluate the Efficacy and Safety of Cetuximab in Combination with Encorafenib Plus Binimetinib As Induction Tre
Phase 2 · 1 location(s) · Spanish Cooperative Group for the Treatment of Digestive Tum · NCT06207656Pembrolizumab Plus Chemo in Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma (Eastern Cooperative Thoracic On
Phase 2 · 2 location(s) · Fudan University · NCT05281003Carvedilol Plus EVL or Not for the Primary Prevention of Esophageal Variceal Bleeding in Carvedilol Non-responders
Phase 4 · 1 location(s) · Taipei Veterans General Hospital, Taiwan · NCT06594783Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Phase 2 · 1 location(s) · Guangzhou JOYO Pharma Co., Ltd · NCT06895031Optimizing Neoadjuvant Treatment Regimens for Locally Advanced Esophageal Squamous Cell Carcinoma
Phase 2/Phase 3 · 1 location(s) · Peking Union Medical College Hospital · NCT06907602Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Phase 1/Phase 2 · 9 location(s) · Sichuan Enray Pharmaceutical Sciences Company · NCT07433283A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · 115 location(s) · Sanofi · NCT06867094Retrospective Analysis of Early Gastric Cancer Patients Based on Prospective Clinical Dataset
Phase N/A · 1 location(s) · Beijing Friendship Hospital · NCT07747688Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
NA · 2 location(s) · University of California, Irvine · NCT06783751Screening for Disorders of Lipid Metabolism and Familial Hyperlipidemia in Children and Adolescents With Increased Cardi
NA · 1 location(s) · Alexandra Miriam Kiess · NCT07716488A Study of Single and Multiple Ascending Doses of H021 in Healthy Participants
Phase 1 · 1 location(s) · Jiangsu Carephar Pharmaceutical Co., Ltd. · NCT06627556Study to Evaluate the Use of Surgical Gloves for the Prevention of Oxaliplatin-Induced Peripheral Neuropathy
NA · 1 location(s) · AC Camargo Cancer Center · NCT07285356Copenhagen Mesenteric Stent Study - A Randomized Trial of Stent Versus Covered Stent Treatment for Chronic Mesenteric Is
NA · 1 location(s) · Rigshospitalet, Denmark · NCT05244629A Clinical Study of Arfolitixorin in Patients With mCRC
Phase 1/Phase 2 · 3 location(s) · Isofol Medical AB · NCT06922383Lymphocyte-sparing Thoracic Radiotherapy for Esophageal Squamous Cell Carcinoma
NA · 1 location(s) · Ruijin Hospital · NCT06596954Prevention of Postoperative Hernias in Emergency Surgery
Phase N/A · 1 location(s) · Jan Kochanowski University · NCT06815822Efficacy and Safety of Penpulimab Combined With Anlotinib and Chemotherapy
Phase 2 · 1 location(s) · Xijing Hospital · NCT06586242A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors
Phase 1 · 2 location(s) · JiaRay Group · NCT06783569Lynch Syndrome X-Talk of Enteral Mucosa With Immune System
Phase N/A · 5 location(s) · San Raffaele University · NCT06708429Fermented Vegan Optimized Diet in Health and Colitis
NA · 2 location(s) · Region Skane · NCT06696222Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric
Phase 1/Phase 2 · 1 location(s) · Henan Cancer Hospital · NCT07334431Standardized Fecal Microbiota Transplantation for Crohn&Apos;s Diseases
NA · 2 location(s) · The Second Hospital of Nanjing Medical University · NCT01793831
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.